• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Application of in-vitro models: development of resistance.

作者信息

Seeberg A H, Wiedemann B

出版信息

J Antimicrob Chemother. 1985 Jan;15 Suppl A:241-9. doi: 10.1093/jac/15.suppl_a.241.

DOI:10.1093/jac/15.suppl_a.241
PMID:3884569
Abstract

The development of chromosomal beta-lactam resistance of Escherichia coli, Enterobacter cloacae and Citrobacter freundii was observed by following the bacterial kill-kinetics in an in-vitro model simulating human serum antibiotic concentrations. From sensitive Escherichia coli cells mutants arose resistant to aminopenicillins, and to first and second generation cephalosporins, whereas with the Ent. cloacae and Citro. freundii mutants were also resistant to cefotaxime. Resistant mutants from all three species could also be selected on antibiotic-containing agar plates. With E. coli they occurred in two steps, the first mutation being stable but the second mutation reverting spontaneously. In Ent. cloacae, and apparently also in Citro. freundii, the mutation changes the cephalosporinase production from an inducible to a constitutive one. The different mutation rates, and the rate was extremely high for some Ent. cloacae strains, were correlated with a corresponding reduction of viable cell count and with the time of re-growth observed in the model.

摘要

相似文献

1
Application of in-vitro models: development of resistance.
J Antimicrob Chemother. 1985 Jan;15 Suppl A:241-9. doi: 10.1093/jac/15.suppl_a.241.
2
Development of resistance to cephalosporins in clinical strains of Citrobacter spp.柠檬酸杆菌临床菌株对头孢菌素耐药性的产生
Antimicrob Agents Chemother. 1984 May;25(5):591-5. doi: 10.1128/AAC.25.5.591.
3
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.FCE 22101及其他β-内酰胺类抗生素对耐第三代头孢菌素肠杆菌科细菌的体外活性
J Antimicrob Chemother. 1989 Aug;24(2):165-72. doi: 10.1093/jac/24.2.165.
4
The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.β-内酰胺酶合成的表型诱导和基因型去阻遏对β-内酰胺敏感性的影响。
J Antimicrob Chemother. 1986 Dec;18 Suppl E:15-22. doi: 10.1093/jac/18.supplement_e.15.
5
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.头孢洛林(PPI-0903M,T-91825)对具有明确耐药机制和表型的细菌的体外活性。
J Antimicrob Chemother. 2007 Aug;60(2):300-11. doi: 10.1093/jac/dkm150. Epub 2007 Jun 4.
6
Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.Sch 34343对链球菌和耐β-内酰胺类肠杆菌科细菌的活性。
J Antimicrob Chemother. 1985 Jun;15 Suppl C:147-54. doi: 10.1093/jac/15.suppl_c.147.
7
Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.革兰氏阴性菌的诱导型I类β-内酰胺酶与对β-内酰胺抗生素的耐药性
J Antimicrob Chemother. 1986 Jan;17(1):51-61. doi: 10.1093/jac/17.1.51.
8
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].[9种β-内酰胺类抗生素与克拉维酸或舒巴坦联合应用对亨利·蒙多医院分离出的产广谱β-内酰胺酶(CTX-1)肠杆菌科菌株的活性]
Pathol Biol (Paris). 1988 May;36(5):425-9.
9
Interactions of FCE 22101 with class I beta-lactamases.FCE 22101与I类β-内酰胺酶的相互作用。
J Antimicrob Chemother. 1989 Mar;23 Suppl C:85-94. doi: 10.1093/jac/23.suppl_c.85.
10
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.阴沟肠杆菌的染色体β-内酰胺酶是导致对第三代头孢菌素耐药的原因。
Antimicrob Agents Chemother. 1983 Jun;23(6):918-25. doi: 10.1128/AAC.23.6.918.

引用本文的文献

1
Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.实现感染治疗的最佳效果。抗菌药物临床药代动力学和药效学的作用。
Clin Pharmacokinet. 1999 Jul;37(1):1-16. doi: 10.2165/00003088-199937010-00001.
2
Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.在体外药代动力学模型中持续和间歇输注头孢他啶期间对铜绿假单胞菌的杀灭作用。
Antimicrob Agents Chemother. 1994 May;38(5):931-6. doi: 10.1128/AAC.38.5.931.
3
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
新型具有强效抗假单胞菌活性的头孢菌素E1040的体外评价
Antimicrob Agents Chemother. 1988 May;32(5):693-701. doi: 10.1128/AAC.32.5.693.